(−)-Nicotine hydrogen tartrate salt
SIGMA/SML1236 - ≥98% (HPLC)
Synonym: (−)-Nicotine ditartrate; (−)-1-Methyl-2-(3-pyridyl)pyrrolidine (+)-bitartrate salt
CAS Number: 65-31-6
Empirical Formula (Hill Notation): C10H14N2 · 2C4H6O6
Molecular Weight: 462.41
EC Number: 200-607-2
Linear Formula: C10H14N2 · 2C4H6O6
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C10H14N2.CH4/c1-12-7-3 |
| InChI key | RYYKFQGHMYGLEL-PPHPATTJSA |
| optical activity | [α]/D +20 to +26°, c = 1.0 in water |
| Quality Level | 100 ![]() |
| SMILES string | CN1CCC[C@H]1C2=CC=CN=C2.C |
| solubility | H2O: 20 mg/mL, clear |
| storage condition | desiccated |
| storage temp. | room temp |
| Application: | (−)-Nicotine hydrogen tartrate salt has been used as an agonist for acetylcholine receptor (AChr). |
| Application: | (−)-Nicotine hydrogen tartrate salt has been used in intracellular calcium imaging. |
| Biochem/physiol Actions: | NHT is considered to be more stable than nicotine. Nicotine is highly addictive drug and is indirectly but strongly associated with tobacco related diseases. It helps to discontinue smoking. Nicotine might serve as a therapeutic agent in treating Alzheimer’s disease, Parkinson’s disease and ulcerative colitis. |
| Biochem/physiol Actions: | Prototype nicotinic acetylcholine receptor agonist; naturally occurring isomer. |
| Packaging: | 1 g in glass bottle |
| Packaging: | 50 mg in glass bottle |
| Symbol | ![]() ![]() GHS06,GHS08,GHS09 |
| Signal word | Danger |
| Hazard statements | H301 - H319 - H330 - H361d - H411 |
| Precautionary statements | P202 - P260 - P264 - P273 - P304 + P340 + P310 - P305 + P351 + P338 |
| RIDADR | UN 1659 6.1 / PGII |
| WGK Germany | WGK 2 |
| Flash Point(F) | 289.8 °F |
| Flash Point(C) | 143.2 °C |
| Purity | ≥98% (HPLC) |
| Storage Temp. | room temp |
| UNSPSC | 12352210 |




